Showing results (311-320 of 329) with videos related to

Sort By:
Pageof 33
Urology|September 25, 1997
Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study GroupP F Schellhammer, R Sharifi, N L Block, et al.
Cancer|November 15, 1985
Buserelin as primary therapy in advanced prostatic carcinomaC A Presant, M S Soloway, S S Klioze, et al.
American Journal of Clinical Pathology|March 1, 1988
The prognostic value of DNA ploidy combined with histologic substaging for incidental carcinoma of the prostate glandT L McIntire, W M Murphy, J S Coon, et al.
BMC Family Practice|May 4, 2018
Implementation of the SMART MOVE intervention in primary care: a qualitative study using normalisation process theoryLiam G Glynn, Fergus Glynn, Monica Casey, et al.
The Prostate|July 27, 1999
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study GroupD G McLeod, P F Schellhammer, N J Vogelzang, et al.
The Journal of Urology|February 1, 1979
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostateJ D Schmidt, W W Scott, R P Gibbons, et al.
Urology|July 22, 1998
Comparison of goserelin and leuprolide in combined androgen blockade therapyM F Sarosdy, P F Schellhammer, R Sharifi, et al.
The Journal of Urology|June 1, 1979
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
Transactions of the American Association of Genito-Urinary Surgeons|January 1, 1978
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiationG P Murphy, R P Gibbons, D E Johnson, et al.
Journal of Hazardous Materials|June 24, 2022
The role of predicted chemotactic and hydrocarbon degrading taxa in natural source zone depletion at a legacy petroleum hydrocarbon siteCameron W M Murphy, Greg B Davis, John L Rayner, et al.
Pageof 33